Portfolio company
Enabling psychedelics-assisted therapies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops psychedelic-inspired medicines and a care delivery model to treat addiction for patients and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Reunion Neuroscience
This biopharmaceutical company develops psychedelic-inspired therapeutic solutions for patients with underserved mental health disorders, such as postpartum depression and anxiety.
Psyon
This company provides psychedelic-assisted psychotherapy and psychiatric care to patients seeking treatment for mental health disorders.
Curio
This company provides technology-enabled psychedelic therapy and coaching services for patients with mental health conditions.
Mycrodose Therapeutics
This pharmaceutical company develops advanced drug delivery systems for psychedelic and cannabinoid compounds to treat mental health and cognitive degenerative diseases.
GH Research
This pharmaceutical company develops psychedelic-based therapies for patients suffering from psychiatric and neurological disorders, including treatment-resistant depression.
Gilgamesh
This clinical-stage biotechnology company develops novel psychedelic-related medicines and chemical entities to treat patients with depression and other neuropsychiatric disorders.
Atai Life Sciences
This biopharmaceutical company develops psychedelic and non-psychedelic therapies for patients living with mental health disorders, including depression, anxiety, and addiction.
Sunstone Therapies
The company provides psychedelic-assisted therapy and clinical trials for patients with cancer and complex mental health conditions.
